Quick Answer
Wave Life Sciences Ltd. reported Operating Income Loss of -$215.38 million for the year ending 2025.
- Wave Life Sciences Ltd. showed a decrease of -95.1% in Operating Income Loss from 2024 to 2025.
- This data is from Wave Life Sciences Ltd.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Wave Life Sciences Ltd.'s Operating Income Loss has declined by 5,926.4%.
- Historical annual values: Fiscal year 2025: -$215.38 million | Fiscal year 2024: -$110.40 million | Fiscal year 2023: -$68.00 million | Fiscal year 2022: -$162.72 million | Fiscal year 2021: -$127.02 million | Fiscal year 2020: -$153.38 million | Fiscal year 2019: -$208.32 million | Fiscal year 2018: -$159.52 million | Fiscal year 2017: -$102.39 million | Fiscal year 2016: -$55.72 million | Fiscal year 2015: -$19.30 million | Fiscal year 2014: -$5.39 million | Fiscal year 2013: -$3.57 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: